Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125174622 | 12517462 | 2 | F | 20160704 | 20160630 | 20160705 | EXP | CN-ROCHE-1786653 | ROCHE | 0.00 | F | Y | 54.00000 | KG | 20160705 | CN | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125174622 | 12517462 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | UNKNOWN | 125085 | 400 | MG | SOLUTION FOR INFUSION | Q3W |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125174622 | 12517462 | 1 | Non-small cell lung cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125174622 | 12517462 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125174622 | 12517462 | Asthenia | |
125174622 | 12517462 | Cardiac disorder | |
125174622 | 12517462 | Dyspnoea | |
125174622 | 12517462 | Hypertension | |
125174622 | 12517462 | Pericardial effusion | |
125174622 | 12517462 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125174622 | 12517462 | 1 | 20150723 | 0 |